- Category
- Micro (2020-21)
- Udyam number
- UDYAM-UP-75-0001960

Namolife Pharma Private Limited
About Namolife Pharma Private Limited
Data last updated:
Namolife Pharma Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 08 February 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85300UP2017PTC090196. Its GSTIN is 09AAFCN4769H1Z0 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandan Singh and Manisha Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Arazi No. 24/2 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001.
As per the financials filed for FY 2023, the company reported a revenue of ₹17.8 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹200 (net margin 0%) and EBITDA of ₹2,101 (EBITDA margin 0.1%).
Namolife Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-75-0001960). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Namolife Pharma
Contact details
Namolife Pharma Private Limited's registered office is in Varanasi, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressArazi No. 24/2 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Namolife Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Namolife Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Namolife Pharma Private Limited, buy the company report.
Financials of Namolife Pharma Private Limited
FY 2025 filings availableNamolife Pharma Private Limited reported revenue of ₹17.8 Lakh (down 31% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 31% in the latest year. EBITDA rose 172% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,101 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹200 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.1% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Namolife Pharma Private Limited, buy the company report.
Board of directors of Namolife Pharma Private Limited
Namolife Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manisha Singh | Additional Director | 06 Jan 2020 | 6 Years 9 Months | Current |
| Chandan Singh | Director | 08 Feb 2017 | 9 Years 8 Months | Current |
Peer comparison
Namolife Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adonia Infrastructure Private Limited | ₹17.81 Lakh (FY 2024) | -29.0% | Kolkata, West Bengal, India | |||
| Panexus Acipl Chemicals Private Limited | ₹17.8 Lakh (FY 2024) | -55.0% | Mumbai, Maharashtra, India | |||
| Glareo Labs Private Limited | ₹17.8 Lakh (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Elixir Vitae Pharmaceuticals Private Limited | ₹17.8 Lakh (FY 2024) | 31.0% | Lucknow, Uttar Pradesh, India | |||
| Sunrise Autocare Private Limited | ₹17.8 Lakh (FY 2024) | -45.0% | Patna, Bihar, India | |||
| Namolife Pharma Private Limitedthis company | ₹17.8 Lakh (FY 2023) | -₹200 | 0% | -31.0% | Varanasi, Uttar Pradesh, India | |
| Ramasharyvision Enterprises Private Limited | ₹17.8 Lakh (FY 2021) | 213.0% | Varanasi, Uttar Pradesh, India | |||
| Hexcy Pharmaceutical Private Limited | ₹17.8 Lakh (FY 2019) | New Delhi, Delhi, India | ||||
| Kaiyaan Lighting Solutions Private Limited | ₹17.79 Lakh (FY 2025) | 47.0% | Chennai, Tamil Nadu, India | |||
| Thendral Organic Private Limited | ₹17.79 Lakh (FY 2024) | 78.0% | Srirangam, Tamil Nadu, India | |||
| Omsaicreations Fabricon & Exports Private Limited | ₹17.79 Lakh (FY 2025) | -90.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Namolife Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Namolife Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Namolife Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Namolife Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN4769H1Z0 | Uttar Pradesh | Active | 04 May 2021 |
To see the full GST registrations and return filing status of Namolife Pharma Private Limited, buy the company report.
Recent activity
Namolife Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Anand Singh ceased to be Director on 04 Feb 2021.
Frequently asked questions
Namolife Pharma is an active private limited company based in Varanasi, Uttar Pradesh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 08 February 2017 (9+ years old) and is registered under CIN U85300UP2017PTC090196.
Namolife Pharma has 2 current directors:
- Manisha Singh - Additional Director
- Chandan Singh - Director
The latest financial statements of Namolife Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Namolife Pharma is 09AAFCN4769H1Z0, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Namolife Pharma is U85300UP2017PTC090196. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Namolife Pharma was incorporated on 08 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Namolife Pharma by revenue are Adonia Infrastructure Private Limited, Panexus Acipl Chemicals Private Limited, Glareo Labs Private Limited, Elixir Vitae Pharmaceuticals Private Limited, Sunrise Autocare Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Anand Singh ceased to be Director on 04 Feb 2021. Manisha Singh was appointed as Additional Director on 06 Jan 2020. Chandan Singh was appointed as Director on 08 Feb 2017.
Yes, Namolife Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-75-0001960).
The registered office of Namolife Pharma is at Arazi No. 242 Maheshpur Shivpur, Varanasi, Uttar Pradesh, India – 221001.
Namolife Pharma operates in the non-profit organizations industry, in the social work segment.